Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 23 studies | 40% ± 18% | |
monocyte | 10 studies | 28% ± 7% | |
alveolar macrophage | 7 studies | 43% ± 18% | |
classical monocyte | 7 studies | 53% ± 21% | |
secretory cell | 7 studies | 28% ± 15% | |
endothelial cell | 6 studies | 19% ± 3% | |
non-classical monocyte | 6 studies | 33% ± 13% | |
myeloid cell | 6 studies | 31% ± 11% | |
fibroblast | 6 studies | 27% ± 11% | |
conventional dendritic cell | 5 studies | 29% ± 6% | |
pericyte | 5 studies | 21% ± 5% | |
endothelial cell of vascular tree | 5 studies | 26% ± 7% | |
mononuclear phagocyte | 4 studies | 34% ± 12% | |
epithelial cell | 4 studies | 28% ± 10% | |
basal cell | 4 studies | 36% ± 15% | |
type II pneumocyte | 3 studies | 22% ± 4% | |
ciliated cell | 3 studies | 24% ± 3% | |
inflammatory macrophage | 3 studies | 28% ± 14% | |
dendritic cell | 3 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 88% | 712.84 | 315 / 359 | 96% | 69.45 | 274 / 286 |
lung | 100% | 1431.14 | 578 / 578 | 69% | 12.93 | 795 / 1155 |
intestine | 69% | 226.48 | 669 / 966 | 98% | 66.04 | 519 / 527 |
pancreas | 53% | 99.41 | 174 / 328 | 79% | 15.59 | 141 / 178 |
esophagus | 37% | 58.24 | 530 / 1445 | 72% | 30.90 | 132 / 183 |
kidney | 81% | 140.98 | 72 / 89 | 14% | 1.06 | 130 / 901 |
spleen | 93% | 195.30 | 225 / 241 | 0% | 0 | 0 / 0 |
prostate | 64% | 187.89 | 157 / 245 | 19% | 2.33 | 94 / 502 |
adipose | 76% | 471.46 | 915 / 1204 | 0% | 0 | 0 / 0 |
uterus | 28% | 37.56 | 48 / 170 | 47% | 10.18 | 216 / 459 |
heart | 73% | 290.85 | 631 / 861 | 0% | 0 | 0 / 0 |
breast | 67% | 132.64 | 309 / 459 | 5% | 0.27 | 55 / 1118 |
bladder | 24% | 65.71 | 5 / 21 | 48% | 20.99 | 240 / 504 |
ovary | 30% | 68.58 | 54 / 180 | 39% | 3.26 | 169 / 430 |
liver | 54% | 73.99 | 121 / 226 | 13% | 1.09 | 53 / 406 |
skin | 48% | 336.53 | 869 / 1809 | 8% | 1.34 | 36 / 472 |
blood vessel | 55% | 134.93 | 730 / 1335 | 0% | 0 | 0 / 0 |
thymus | 42% | 67.14 | 271 / 653 | 13% | 0.74 | 78 / 605 |
tonsil | 0% | 0 | 0 / 0 | 49% | 4.58 | 22 / 45 |
brain | 22% | 27.76 | 572 / 2642 | 25% | 2.66 | 178 / 705 |
adrenal gland | 29% | 63.70 | 74 / 258 | 5% | 1.41 | 12 / 230 |
muscle | 19% | 20.48 | 155 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 16% | 35.27 | 152 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.09 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0045236 | Molecular function | CXCR chemokine receptor binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CXCL3 |
Protein name | C-X-C motif chemokine 3 (GRO-gamma(1-73)) (Growth-regulated protein gamma) (GRO-gamma) (Macrophage inflammatory protein 2-beta) (MIP2-beta) [Cleaved into: GRO-gamma(5-73)] |
Synonyms | SCYB3 GRO3 GROG |
Description | FUNCTION: Ligand for CXCR2 (By similarity). Has chemotactic activity for neutrophils. May play a role in inflammation and exert its effects on endothelial cells in an autocrine fashion. In vitro, the processed form GRO-gamma(5-73) shows a fivefold higher chemotactic activity for neutrophilic granulocytes. . |
Accessions | P19876 ENST00000296026.4 |